$67.41
-0.84%Somni is a company specializing in sleep technology and wellness solutions, developing innovative products to enhance sleep quality. The company integrates science-backed methods, smart technology, and data-driven insights to improve sleep patterns and overall well-being.
Total Payments
29
Latest Dividend
$0.1700
Annual Amount
$0.7900
Frequency
Quarterly
| Declaration | Ex-Date | Payment Date | Dividend | Adjusted | Frequency | Growth |
|---|---|---|---|---|---|---|
May 6, 2026 | May 21, 2026 | Jun 4, 2026 | $0.1700 | $0.1700 | Quarterly | 0.00% |
Feb 16, 2026 | Mar 5, 2026 | Mar 19, 2026 | $0.1700 | $0.1700 | Quarterly | +13.33% |
Nov 6, 2025 | Nov 20, 2025 | Dec 4, 2025 | $0.1500 | $0.1500 | Quarterly | 0.00% |
Aug 7, 2025 | Aug 21, 2025 | Sep 5, 2025 | $0.1500 | $0.1500 | Quarterly | 0.00% |
May 8, 2025 | May 22, 2025 | Jun 5, 2025 | $0.1500 | $0.1500 | Quarterly | 0.00% |
Feb 20, 2025 | Mar 6, 2025 | Mar 20, 2025 | $0.1500 | $0.1500 | Quarterly | +15.38% |
Nov 7, 2024 | Nov 21, 2024 | Dec 5, 2024 | $0.1300 | $0.1300 | Quarterly | 0.00% |
Aug 6, 2024 | Aug 15, 2024 | Aug 29, 2024 | $0.1300 | $0.1300 | Quarterly | 0.00% |
May 7, 2024 | May 16, 2024 | May 30, 2024 | $0.1300 | $0.1300 | Quarterly | 0.00% |
Feb 8, 2024 | Feb 22, 2024 | Mar 7, 2024 | $0.1300 | $0.1300 | Quarterly | +18.18% |
Nov 2, 2023 | Nov 16, 2023 | Dec 4, 2023 | $0.1100 | $0.1100 | Quarterly | 0.00% |
Aug 3, 2023 | Aug 17, 2023 | Aug 31, 2023 | $0.1100 | $0.1100 | Quarterly | 0.00% |
May 9, 2023 | May 23, 2023 | Jun 6, 2023 | $0.1100 | $0.1100 | Quarterly | 0.00% |
Feb 9, 2023 | Feb 23, 2023 | Mar 9, 2023 | $0.1100 | $0.1100 | Quarterly | +10.00% |
Nov 3, 2022 | Nov 17, 2022 | Dec 1, 2022 | $0.1000 | $0.1000 | Quarterly | 0.00% |
Jul 27, 2022 | Aug 11, 2022 | Aug 25, 2022 | $0.1000 | $0.1000 | Quarterly | 0.00% |
Apr 28, 2022 | May 12, 2022 | May 26, 2022 | $0.1000 | $0.1000 | Quarterly | 0.00% |
Feb 22, 2022 | Mar 8, 2022 | Mar 22, 2022 | $0.1000 | $0.1000 | Quarterly | +11.11% |
Oct 28, 2021 | Nov 11, 2021 | Nov 23, 2021 | $0.0900 | $0.0900 | Quarterly | 0.00% |
Jul 29, 2021 | Aug 12, 2021 | Aug 26, 2021 | $0.0900 | $0.0900 | Quarterly | +28.57% |
Apr 29, 2021 | May 13, 2021 | May 27, 2021 | $0.0700 | $0.0700 | Quarterly | 0.00% |
Feb 11, 2021 | Feb 25, 2021 | Mar 12, 2021 | $0.0700 | $0.0700 | Quarterly | +250.00% |
N/A | Aug 29, 2008 | Sep 12, 2008 | $0.0800 | $0.0200 | Quarterly | 0.00% |
N/A | May 31, 2008 | Jun 14, 2008 | $0.0800 | $0.0200 | Quarterly | 0.00% |
N/A | Feb 27, 2008 | Mar 14, 2008 | $0.0800 | $0.0200 | Quarterly | 0.00% |
N/A | Nov 30, 2007 | Dec 14, 2007 | $0.0800 | $0.0200 | Quarterly | 0.00% |
N/A | Aug 31, 2007 | Sep 14, 2007 | $0.0800 | $0.0200 | Quarterly | 0.00% |
N/A | May 31, 2007 | Jun 14, 2007 | $0.0800 | $0.0200 | Quarterly | +33.33% |
N/A | Feb 27, 2007 | Mar 14, 2007 | $0.0600 | $0.0150 | Quarterly | - |
Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.
Excellent FCF coverage. Dividend is well-supported by actual cash generation with ample room for increases and business reinvestment.
Significant dividend reduction signals serious challenges. Company prioritizing financial stability over shareholder returns. High risk of further cuts.
Sustainable dividend with adequate coverage. Some areas for improvement but overall appears safe for dividend investors.
Recent dividend cut signals distress: Management forced to reduce payout, indicating financial pressure. Evaluate whether business challenges are temporary or structural before reinvesting.
Continue your SGI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.